Exploring the interaction of myricetin with human alpha-2-macroglobulin: biophysical and in-silico analysis.

Alpha-2-macroglobulin CD FRET Flavonoids Molecular docking Myricetin Protease inhibitor Spectroscopy α2M

Journal

Journal of biological physics
ISSN: 1573-0689
Titre abrégé: J Biol Phys
Pays: Netherlands
ID NLM: 0417731

Informations de publication

Date de publication:
03 2023
Historique:
received: 04 10 2022
accepted: 26 12 2022
pubmed: 21 1 2023
medline: 3 3 2023
entrez: 20 1 2023
Statut: ppublish

Résumé

Myricetin (MYR) is a bioactive secondary metabolite found in plants that is recognized for its nutraceutical value and is an essential constituent of various foods and beverages. It is reported to exhibit a plethora of activities, including antioxidant, antimicrobial, antidiabetic, anticancer, and anti-inflammatory. Alpha-2-macroglobulin (α2M) is a major plasma anti-proteinase that can inhibit proteinases of both human and non-human origin, regardless of their specificity and catalytic mechanism. Here, we explored the interaction of MYR-α2M using various biochemical and biophysical techniques. It was found that the interaction of MYR brings subtle change in its anti-proteolytic potential and thereby alters its structure and function, as can be seen from absorbance and fluorescence spectroscopy. UV spectroscopy of α2M in presence of MYR indicated the occurrence of hyperchromism, suggesting complex formation. Fluorescence spectroscopy reveals that MYR reduces the fluorescence intensity of native α2M with a shift in the wavelength maxima. At 318.15 K, MYR binds to α2M with a binding constant of 2.4 × 10

Identifiants

pubmed: 36662317
doi: 10.1007/s10867-022-09621-z
pii: 10.1007/s10867-022-09621-z
pmc: PMC9867608
doi:

Substances chimiques

myricetin 76XC01FTOJ
Pregnancy-Associated alpha 2-Macroglobulins 0
Flavonoids 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

29-48

Subventions

Organisme : King Saud University, Riyadh, Saudi Arabia
ID : RSP-2021/393

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Nature B.V.

Références

Bioimpacts. 2019;9(2):115-121
pubmed: 31334043
Clin Chim Acta. 1966 Oct;14(4):493-501
pubmed: 5971885
Nature. 1970 Aug 15;227(5259):680-5
pubmed: 5432063
Int J Biol Macromol. 2016 Feb;83:366-75
pubmed: 26608004
J Mol Biol. 2022 Mar 15;434(5):167413
pubmed: 34942166
Food Chem Toxicol. 2021 Jul;153:112265
pubmed: 34004225
Nutrients. 2021 Jan 24;13(2):
pubmed: 33498897
Spectrochim Acta A Mol Biomol Spectrosc. 2020 Dec 15;243:118731
pubmed: 32827907
Phytother Res. 2021 Sep;35(9):4660-4702
pubmed: 33847440
BMC Complement Med Ther. 2020 Aug 1;20(1):241
pubmed: 32738903
Nutrients. 2016 Feb 16;8(2):90
pubmed: 26891321
Food Sci Nutr. 2021 Aug 11;9(10):5854-5868
pubmed: 34646551
J Biomol Struct Dyn. 2020 Sep;38(14):4107-4118
pubmed: 31543004
Mol Cell Endocrinol. 2005 Dec 21;245(1-2):60-6
pubmed: 16297527
Spectrochim Acta A Mol Biomol Spectrosc. 2017 Sep 5;184:191-197
pubmed: 28499172
Mol Cell Biochem. 2021 Jan;476(1):57-68
pubmed: 32851589
Molecules. 2018 Mar 27;23(4):
pubmed: 29584636
J Biomol Struct Dyn. 2022 Sep;40(15):6683-6696
pubmed: 33634734
Curr Protein Pept Sci. 2020 Nov 08;:
pubmed: 33167830
J Cell Physiol. 2013 Aug;228(8):1665-75
pubmed: 23086799
Int J Biol Macromol. 2018 Sep;116:721-727
pubmed: 29751037
Environ Toxicol Pharmacol. 2010 Jan;29(1):12-8
pubmed: 21787576
Cardiovasc Toxicol. 2017 Jul;17(3):277-286
pubmed: 27484498
Front Pharmacol. 2021 Jun 17;12:669642
pubmed: 34220507
Pharmaceutics. 2021 May 05;13(5):
pubmed: 34062983
Spectrochim Acta A Mol Biomol Spectrosc. 2021 Feb 5;246:118977
pubmed: 33017787
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
Molecules. 2018 Jan 27;23(2):
pubmed: 29382045
Spectrochim Acta A Mol Biomol Spectrosc. 2021 Jun 5;254:119664
pubmed: 33743310
South Asian J Cancer. 2014 Apr;3(2):107-11
pubmed: 24818105
Int J Biol Macromol. 2020 May 1;150:727-736
pubmed: 32061704
Biochemistry. 1981 May 26;20(11):3096-102
pubmed: 7248271
Planta Med. 2008 Nov;74(14):1667-77
pubmed: 18937165
Curr Drug Metab. 2013 May;14(4):491-503
pubmed: 23330929
J Environ Sci Health A Tox Hazard Subst Environ Eng. 2022;57(12):997-1002
pubmed: 36285349

Auteurs

Sana Ansari (S)

Department of Biochemistry, Faculty of Life Sciences, Aligarh Muslim University, Aligarh - 202002, India.

Haseeb Ahsan (H)

Department of Biochemistry, Faculty of Dentistry, Jamia Millia Islamia, New Delhi - 110025, India.

Mohammad Khalid Zia (MK)

Department of Biochemistry, Faculty of Life Sciences, Aligarh Muslim University, Aligarh - 202002, India.

Mansour K Gatasheh (MK)

Department of Biochemistry, College of Science, King Saud University, PO Box 2455, Riyadh - 11451, Saudi Arabia.

Fahim H Khan (FH)

Department of Biochemistry, Faculty of Life Sciences, Aligarh Muslim University, Aligarh - 202002, India. fahimhkhan@rediffmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH